在急性失补偿性HF中,将乙醇胺添加到IV循环利尿剂减少了eGFR水平在3d的拥堵
Daniel Rospert1, Donald A Molony1
1McGovern Medical School, UTHealth-University of Texas, Houston, Texas, USA (D.R., D.A.M.).
Annals of internal medicine
|January 1, 2024
概括
在急性不补偿性心力衰竭患者中,乙醇胺改善了功能,并减少了液体过载. 这一发现为心力衰竭管理提供了新的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 经常导致心脏病综合征.
- 尿剂耐药性是ADHF的常见并发症,需要使用替代治疗策略.
- 优化脱血和维护功能是ADHF管理的关键目标.
研究的目的:
- 为了研究乙醇胺对ADHF患者功能和脱血的作用.
- 评估乙醇胺作为标准利尿剂的补充疗法的疗效.
主要方法:
- ADVOR试验是一项随机,双盲,安慰剂控制的研究.
- 患有ADHF的患者除了循环利尿剂外,还接受了乙胺或安慰剂.
- 评估了功能 (eGFR) 和流体状况 (体重变化,净流体平衡).
主要成果:
- 与安慰剂相比,乙醇胺显著改善了估计的淋巴膜过率 (eGFR).
- 接受乙醇胺治疗的患者获得了更大的液体排出和体重减轻.
- 在乙醇胺组中没有观察到不良事件的显著增加.
结论:
- 乙胺增强了脱血,并改善了ADHF患者的功能.
- 这表明乙胺是治疗心力衰竭中心脏脏综合征的有价值的治疗选择.
- 该ADVOR试验提供了证据,证明了一种新的方法来治疗ADHF的尿剂耐药性.
相关概念视频
Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Antihypertensive Drugs: Action of Diuretics
703
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
703
Antihypertensive Drugs: Potassium-Sparing Diuretics
569
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
569
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Renal Failure: Dose Adjustments
94
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94


